A global field study of the international classification of diseases (ICD-11) mood disorders clinical descriptions and diagnostic guidelines

Kogan, Cary S.; Maj, Mario; Rebello, Tahilia J.; Keeley, Jared W.; Kulygina, Maya; Matsumoto, Chihiro; Robles, Rebeca; Huang, Jingjing; Zhong, Na; Chakrabarti, Subho; Figueira, Maria Luísa; Stein, Dan J.; Strakowski, Stephen M.; Garcia-Pacheco, José A; Burns, Samantha C.; Montoya, Madeline I; Andrade, Laura Helena; Ayuso-Mateos, José Luís; Arango, Iván; Balhara, Yatan Pal Singh; Bryant, Richard A.; Cournos, Francine; Porto, José Alberto Del; Meyer, Thomas D.; Medina-Mora, María-Elena; Gureje, Oye; First, Michael B.; Gäebel, Wolfgang; Khoury, Brigitte; Краснов, В.; Mari, Jair de Jesus; Maruta, Toshimasa; Pike, Kathleen M.; Roberts, Michael C.; Sharan, Pratap; Zhao, Min; Reed, Geoffrey M.

doi:10.1016/j.jad.2021.08.050

Cited by 12 publications

(10 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There was a divergence of opinion between psychiatrists and other mental health professionals in certain studies[ 151 , 153 ]. Although the ICD-11 categories were not inferior to the ICD-10 ones in terms of utility and reliability, there were no substantial differences between the two versions[ 155 , 156 , 161 , 162 ]. The reliability of BP-II disorder though adequate was relatively low[ 157 ].…”

Section: Summary Of the Changes Madementioning

confidence: 92%

“…The overall structure of the ICD-11 version and the structure of the mood disorders section was endorsed by the clinicians[ 23 , 24 ]. The diagnostic accuracy of BP-II disorders in the ICD-11 CDDR was better than that in the ICD-10 guidelines[ 155 , 156 ]. The clinical utility and inter-rater reliability of BP-I disorder, BD, and mood disorders all proved to be high[ 142 , 157 - 160 ].…”

Section: Summary Of the Changes Madementioning

confidence: 99%

See 1 more Smart Citation

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Chakrabarti¹

2022

World J Psychiatry

Self Cite

View full text Add to dashboard Cite

The World Health Organization’s 11 th revision of the International Classification of Diseases (ICD-11) including the chapter on mental disorders has come into effect this year. This review focuses on the “Bipolar or Related Disorders” section of the ICD-11 draft. It describes the benchmarks for the new version, particularly the foremost principle of clinical utility. The alterations made to the diagnosis of bipolar disorder (BD) are evaluated on their scientific basis and clinical utility. The change in the diagnostic requirements for manic and hypomanic episodes has been much debated. Whether the current criteria have achieved an optimum balance between sensitivity and specificity is still not clear. The ICD-11 definition of depressive episodes is substantially different, but the lack of empirical support for the changes has meant that the reliability and utility of bipolar depression are relatively low. Unlike the Diagnostic and Statistical Manual of Mental Disorders, 5 th edition (DSM-5), the ICD-11 has retained the category of mixed episodes. Although the concept of mixed episodes in the ICD-11 is not perfect, it appears to be more inclusive than the DSM-5 approach. Additionally, there are some uncertainties about the guidelines for the subtypes of BD and cyclothymic disorder. The initial results on the reliability and clinical utility of BD are promising, but the newly created diagnostic categories also appear to have some limitations. Although further improvement and research are needed, the focus should now be on facing the challenges of implementation, dissemination, and education and training in the use of these guidelines.

show abstract

Section: Summary Of the Changes Madementioning

confidence: 92%

Section: Summary Of the Changes Madementioning

confidence: 99%

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Chakrabarti¹

2022

World J Psychiatry

Self Cite

View full text Add to dashboard Cite

show abstract

“…Other OCRDs include body dysmorphic disorder (obsessions and compulsions focused on bodily appearance), hypochondriasis (obsessions focused on serious illness with compulsive medical reassurance seeking), hoarding disorder (compulsive acquisition or failure to discard items), olfactory reference disorder (obsessions and compulsions focused on smelling offensive), hair pulling disorder and skin picking disorder. Field studies have indicated that the ICD‐11 method of ‘group’ classification leads to improved recognition by non‐specialist clinicians of these often overlooked disorders 17 . It is important for clinicians to be aware of these other disorders and to enquire about them in all suspected cases of OCD, as their presence may affect the care plan.…”

Section: Diagnosis and Classificationmentioning

confidence: 99%

“…Field studies have indicated that the ICD-11 method of 'group' classification leads to improved recognition by non-specialist clinicians of these often overlooked disorders. 17 It is important for clinicians to be aware of these other disorders and to enquire about them in all suspected cases of OCD, as their presence may affect the care plan.…”

Section: Diagnosis and Classificationmentioning

confidence: 99%

Obsessive‐compulsive disorder and men's health. Part 1: Recognition and diagnosis

Conti

Pellegrini

Riaz

et al. 2023

Trends Urol & Men's Health

View full text Add to dashboard Cite

Obsessive‐compulsive disorder (OCD) commonly affects males and can manifest with a range of urological symptoms directly linked to the content of the OCD, including urinary urgency, urinary frequency, urinary retention and sexual dysfunction. Accurate recognition of OCD in such cases is fundamental to avoid misdiagnosis, risks to patients associated with untreated OCD (including suicidal behaviour), unnecessary physical health investigations and delayed treatment. In Part 1 here, the authors discuss the recognition and diagnosis of OCD. Part 2 will consider its treatment.

show abstract

“…Clinicians may disagree about whether functional impairment in a patient is or is not “marked”, in the absence of further specification (justified by the lack of relevant research evidence). This may contribute to the difficulties recently noted in the differentiation between bipolar I and II disorder 23 . Furthermore, clinical judgement about the degree of functional impairment is likely to be influenced by cultural and even gender considerations, especially when the domain of social relationships is considered.…”

Section: Psychopathological Components Of Mania/hypomaniamentioning

confidence: 99%

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

et al. 2022

Self Cite

View full text Add to dashboard Cite

Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to treatment. Despite evidence for the efficacy of multimodal ity interventions, the majority of persons affected by this disorder do not achieve and sustain full syndromal recovery. It is eagerly anticipated that combining datasets across various information sources (e.g., hierarchical "multiomic" measures, electronic health records), analyzed using ad vanced computational methods (e.g., machine learning), will inform future diagnosis and treatment selection. In the interim, identifying clinically meaningful subgroups of persons with the disorder having differential response to specific treatments at pointofcare is an empirical priority. This paper endeavours to synthesize salient domains in the clinical characterization of the adult patient with bipolar disorder, with the overarching aim to improve health outcomes by informing patient management and treatment considerations. Extant data indicate that characterizing select domains in bipolar disorder provides actionable information and guides shared decision making. For example, it is robustly established that the presence of mixed features -especially during depressive episodes -and of physical and psychiatric comorbidities informs illness trajectory, response to treatment, and suicide risk. In addition, early environmental exposures (e.g., sexual and physical abuse, emotional neglect) are highly associated with more complicated illness presentations, inviting the need for developmentallyoriented and integrated treatment approaches. There have been significant advances in validating subtypes of bipolar disorder (e.g., bipolar I vs. II disorder), particularly in regard to pharmacological interventions. As with other severe mental disorders, social functioning, interpersonal/family relationships and internalized stigma are domains highly relevant to relapse risk, health outcomes, and quality of life. The elevated standardized mortality ratio for completed suicide and suicidal behaviour in bipolar disorder invites the need for characterization of this domain in all patients. The framework of this paper is to describe all the above salient domains, provid ing a synthesis of extant literature and recommendations for decision support tools and clinical metrics that can be implemented at pointofcare.

show abstract

A global field study of the international classification of diseases (ICD-11) mood disorders clinical descriptions and diagnostic guidelines

Cited by 12 publications

References 38 publications

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness

Obsessive‐compulsive disorder and men's health. Part 1: Recognition and diagnosis

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

Contact Info

Product

Resources

About